Riskpilot← Back to searchSign inGet full accessBIFOMED A/S
A/SIn liquidationCVR 31154774Bogbinderivej 6Investeringsselskaber · NACE 643030Est. 2007— employees
Revenue 2021
DKK -114K
EBITDA margin
108.7%
-169% vs 2020
Equity ratio
90.2%
Financial strength
Net profit 2021
DKK 18M
+32446% vs 2020
| Revenue | DKK -114K | — |
| EBITDA | DKK -124K | -169% |
| Net profit | DKK 18M | +32446% |
| Total assets | DKK 12,2M | -6% |
| Equity | DKK 11M | -15% |
| Employees | — | — |
Legal name
BIFOMED A/S
CVR number
31154774
Legal form
Aktieselskab
NACE code
643030 · Investeringsselskaber
Founded
13. december 2007
Share capital
DKK 540.292
Employees
—
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Bogbinderivej 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -29 | -24 | -30 | -50 | -30 | -465 | -10 | -43 | 0 | -114 |
| Staff expenses | -0 | -0 | -0 | -0 | -20 | -20 | -20 | -20 | -10 | -10 |
| EBITDA | -29 | -24 | -30 | -50 | -50 | -485 | -30 | -63 | -46 | -124 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -29 | -24 | -30 | -50 | -50 | -485 | -30 | -63 | -46 | -124 |
| Net financials | 40 | 38 | 1 | 1.964 | 2.314 | 1.353 | 2.710 | 78.986 | -9 | 18.182 |
| Profit before tax | 12 | 15 | -29 | 1.915 | 2.263 | 868 | 2.680 | 78.924 | -56 | 18.058 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 68 |
| Net profit | 12 | 15 | -29 | 1.915 | 2.263 | 868 | 2.680 | 78.924 | -56 | 17.989 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 6.616 | 6.631 | 6.115 | 10.345 | 11.078 | 12.222 | 14.953 | 16.143 | 13.052 | 12.235 |
| Equity | 6.520 | 6.535 | 6.012 | 10.157 | 10.865 | 11.732 | 14.412 | 16.132 | 13.041 | 11.031 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 96 | 96 | 103 | 189 | 214 | 489 | 541 | 11 | 11 | 1.204 |
| Total debt | 96 | 96 | 103 | 189 | 214 | 489 | 541 | 11 | 11 | 1.204 |
EBITDA margin
-12433400.0%
This company
15.8%
Market median
-78692505% vs market
20122021
Equity ratio
90.2%
This company
38.2%
Market median
+136% vs market
20122021
Return on equity
163.1%
This company
18.4%
Market median
+786% vs market
20122021
Net profit margin
1798934000.0%
This company
8.1%
Market median
+22209061628% vs market
20122021
Asset turnover
-0.01×
This company
1.12×
Market median
-101% vs market
20122021
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20122021
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CS Founder | Founder | 2007 | — | — |
KR Founder | Founder | 2007 | — | — |
HK Unofficial title | Unofficial title | 2022 | — | — |
ML Founder | Founder | 2007 | — | — |
DC Founder | Founder | 2007 | — | — |
MM Founder | Founder | 2007 | — | — |
MK Founder | Founder | 2007 | — | — |
EM Founder | Founder | 2007 | — | — |
PM Founder | Founder | 2007 | — | — |
SC Management | Management | 2007 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ERB ApS | Company | 15.0% | 15.0% | 2021 |
H HARBORG ApS | Company | 15.0% | 15.0% | 2007 |
JUB INVEST ApS | Company | 10.0% | 10.0% | 2010 |
| Individual | 5.0% | 5.0% | 2010 | |
| Individual | 15.0% | 15.0% | 2015 | |
| Individual | 15.0% | 15.0% | 2010 | |
| Individual | 10.0% | 10.0% | 2010 | |
NPB ApS | Company | 15.0% | 15.0% | 2010 |
MH-H ApS | Company | 15.0% | 15.0% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIFOMED A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Claus Søren Bonde | Founder | 0 companies |
| Kjeld Rahbek Ryttig | Founder | 0 companies |
| Henrik Kring Schmidt | Unofficial title | 0 companies |
| Mette Lindeskov Agertoft | Founder | 0 companies |
| Dan Christian Petersen | Founder | 0 companies |
| Marianne Mikkelsen | Founder | 0 companies |
| Maybrit Kort Hansen | Founder | 0 companies |
| Elsebeth Marcher | Founder | 0 companies |
| Palle Marius Hansen | Founder | 0 companies |
| Steen Christensen | Management | 0 companies |
| Hans Harborg | Board of Directors | 0 companies |
| Mikkel Ole Hvid-Hansen | Board of Directors | 0 companies |
| Sonny Eddie Mikkelsen | Board of Directors | 0 companies |